Protalix BioTherapeutics PLX
NYSE PLX
$2.57 -0.01 (-0.39%)
At close: Oct 22, 2026 · 4:00 PM EDT

Protalix BioTherapeutics (PLX) Depreciation and Depletion (2015 - 2026)

Updated

Protalix BioTherapeutics (PLX) recorded Depreciation and Depletion of $132,000 in Q2 2026, up 12.8% from $117,000 a year earlier but down 67.3% from the prior quarter.

Analysis

Protalix BioTherapeutics (PLX) Depreciation and Depletion (2015 - 2026) Analysis & Trends

On a TTM basis, Protalix BioTherapeutics' Depreciation and Depletion came in at $1.3 million as of Jun 30, 2026, up 15.0% year-over-year; for FY2025, it came in at $1.47 million, up 12.3% from FY2024.

  • Annual Depreciation and Depletion has increased for three straight years, with a five-year compound annual growth rate of 2.4% (FY2020 to FY2025).
  • Across earlier years, Depreciation and Depletion came in at $1.3 million in FY2024 (+9.5%), $1.19 million in FY2023 (+8.3%), $1.1 million in FY2022 (-1.6%) and $1.12 million in FY2021 (-14.1%).
  • Quarterly Depreciation and Depletion has ranged from $117,000 in Q2 2025 to $404,000 in Q1 2026 over the past five years.
  • On a year-over-year basis, Depreciation and Depletion has increased for four consecutive quarters, with growth averaging 2.2% over the last eight quarters.
  • Peak year-over-year performance for Depreciation and Depletion in the last five years was growth of 16.8% in Q1 2026, against a decline of 63.3% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $404,000 (Q1 2026), $387,000 (Q4 2025) and $372,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 194.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 98.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Protalix BioTherapeutics 207.07 Mn 55.69 Mn 12.13 Mn 132,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 132,000.00
Mar 31, 2026 404,000.00
Dec 31, 2025 387,000.00
Sep 30, 2025 372,000.00
Jun 30, 2025 117,000.00
Mar 31, 2025 346,000.00
Dec 31, 2024 334,000.00
Sep 30, 2024 329,000.00
Jun 30, 2024 319,000.00
Mar 31, 2024 322,000.00
Dec 31, 2023 313,000.00
Sep 30, 2023 305,000.00
Jun 30, 2023 293,000.00
Mar 31, 2023 280,000.00
Dec 31, 2022 289,000.00
Sep 30, 2022 273,000.00
Jun 30, 2022 268,000.00
Mar 31, 2022 270,000.00
Dec 31, 2021 259,000.00
Sep 30, 2021 285,000.00
API Access

Protalix BioTherapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=PLX&period=max&api_key=YOUR_API_KEY